Các bài viết có thể truy cập công khai - Grant McArthurTìm hiểu thêm
Không có ở bất kỳ nơi nào: 23
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
GV Long, V Atkinson, S Lo, S Sandhu, AD Guminski, MP Brown, ...
The Lancet Oncology 19 (5), 672-681, 2018
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Melanoma
D Schadendorf, DE Fisher, C Garbe, JE Gershenwald, JJ Grob, A Halpern, ...
Nature reviews Disease primers 1 (1), 1-20, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health
Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study
A Ribas, R Gonzalez, A Pavlick, O Hamid, TF Gajewski, A Daud, ...
The lancet oncology 15 (9), 954-965, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health, National Health and Medical Research …
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
MJ Bywater, RB Pearson, GA McArthur, RD Hannan
Nature Reviews Cancer 13 (5), 299-314, 2013
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Combined CDK4/6 and PI3Kα inhibition is synergistic and immunogenic in triple-negative breast cancer
ZL Teo, S Versaci, S Dushyanthen, F Caramia, P Savas, CP Mintoff, ...
Cancer research 77 (22), 6340-6352, 2017
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer
JC Chan, KM Hannan, K Riddell, PY Ng, A Peck, RS Lee, S Hung, ...
Science signaling 4 (188), ra56-ra56, 2011
Các cơ quan ủy nhiệm: Swiss National Science Foundation
Targeting oncogenic drivers and the immune system in melanoma
GA McArthur, A Ribas
Journal of clinical oncology 31 (4), 499-506, 2013
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib
CH Choe, GA McArthur, I Caro, JH Kempen, RK Amaravadi
American Journal of Ophthalmology 158 (4), 831-837. e2, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health
CDK4/6 inhibition promotes antitumor immunity through the induction of T-cell memory
EJ Lelliott, IY Kong, M Zethoven, KM Ramsbottom, LG Martelotto, ...
Cancer discovery 11 (10), 2582-2601, 2021
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia, Netherlands …
Combination anti-CTLA-4 and anti-RANKL in metastatic melanoma
MJ Smyth, H Yagita, GA McArthur
Journal of Clinical Oncology 34 (12), e104-e106, 2016
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma
VJ Mar, SQ Wong, A Logan, T Nguyen, J Cebon, JW Kelly, R Wolfe, ...
Pigment cell & melanoma research 27 (6), 1117-1125, 2014
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
The role of BRAF mutations in primary melanoma growth rate and survival
VJ Mar, W Liu, B Devitt, SQ Wong, A Dobrovic, GA McArthur, R Wolfe, ...
British Journal of Dermatology 173 (1), 76-82, 2015
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Correlation of p 16 status, hypoxic imaging using [18 F]‐misonidazole positron emission tomography and outcome in patients with loco‐regionally advanced head and neck cancer
ME Trinkaus, RJ Hicks, RJ Young, LJ Peters, B Solomon, M Bressel, ...
Journal of medical imaging and radiation oncology 58 (1), 89-97, 2014
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia, Canadian Institutes …
Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
X Zhang, JZ Tang, IA Vergara, Y Zhang, P Szeto, L Yang, C Mintoff, ...
Molecular Cancer Research 17 (7), 1435-1449, 2019
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
γδ T cells in Merkel cell carcinomas have a proinflammatory profile prognostic of patient survival
NA Gherardin, K Waldeck, A Caneborg, LG Martelotto, S Balachander, ...
Cancer immunology research 9 (6), 612-623, 2021
Các cơ quan ủy nhiệm: Australian Research Council, National Health and Medical Research Council …
Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations
AJ Colebatch, T Witkowski, PM Waring, GA McArthur, SQ Wong, ...
Clinical chemistry 64 (4), 745-747, 2018
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Co‐targeting bromodomain and extra‐terminal proteins and MCL1 induces synergistic cell death in melanoma
HY Tseng, J Dreyer, AA Emran, D Gunatilake, M Pirozyan, C Cullinane, ...
International journal of cancer 147 (8), 2176-2189, 2020
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
ATRA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells
LCY Chee, J Hendy, LE Purton, GA McArthur
Leukemia 27 (6), 1369-1380, 2013
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Clinicopathological characteristics associated with BRAFK601E and BRAFL597 mutations in melanoma
M Voskoboynik, V Mar, S Mailer, A Colebatch, A Fennessy, A Logan, ...
Pigment cell & melanoma research 29 (2), 222-228, 2016
Các cơ quan ủy nhiệm: US National Institutes of Health
Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study
GV Long, V Atkinson, SN Lo, AD Guminski, SK Sandhu, MP Brown, ...
The Lancet Oncology, 2025
Các cơ quan ủy nhiệm: National Health and Medical Research Council, Australia
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ